Search

Your search keyword '"Leverger, Guy"' showing total 1,017 results

Search Constraints

Start Over You searched for: Author "Leverger, Guy" Remove constraint Author: "Leverger, Guy"
1,017 results on '"Leverger, Guy"'

Search Results

2. Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group

3. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

4. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus

5. NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells

6. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration

9. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias

10. Rapport 24-07. Maltraitance physique chez l’enfant : Améliorer le repérage, le diagnostic et la prise en charge dans le secteur de la santé

11. Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome

12. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study

13. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)

14. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation

15. Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

16. Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study

18. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)

19. Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients

20. Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus

21. Ovarian Function and Spontaneous Pregnancy After Hematopoietic Stem Cell Transplantation for Leukemia Before Puberty: An L.E.A. Cohort Study

22. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes

23. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

25. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations

26. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients

27. Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia

28. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia

29. Neurological Involvement in Childhood Evans Syndrome

31. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias

32. P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS

33. A 10‐year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?

36. Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.

37. Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia

39. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group

40. Adolescents and young adults with newly diagnosed primary immune thrombocytopenia

41. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia : An I-BFM Study Group collaboration

42. Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia : a study by the international Berlin-Frankfurt-Münster study group

43. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia:A Study by the International Berlin-Frankfurt-Munster Study Group

45. The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study

47. Comprehensive mutational profiling of core binding factor acute myeloid leukemia

50. Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia

Catalog

Books, media, physical & digital resources